Start page Newsroom All news Newsroom type All Releases Articles year All years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 Orion comments on ANDA filed by Mylan Pharmaceuticals Inc. for a generic version of Orion's proprietary drug Comtan® (entacapone) in the United States 12/15/2010 Stock exchange release 321,946 Orion A-shares converted into B-shares 11/12/2010 Stock exchange release Composition of the Nomination Committee of Orion Corporation 11/1/2010 Stock exchange release Orion Group Interim Report January-September 2010 10/26/2010 Stock exchange release European Medicines Agency has initiated the review of Orion´s dexmedetomidine marketing authorisation application 10/20/2010 Stock exchange release Disclosure Under Chapter 2 Section 9 10/15/2010 Flagging notifications Orion invites analysts and media to Q3 news conference on Tuesday 26 October 2010 10/11/2010 Stock exchange release Change in Orion Group Executive Management Board as of 1 Jan 2011 9/24/2010 Stock exchange release Orion: Change in the holding of own shares 9/1/2010 Stock exchange release Orion comments on today's FDA release on safety review of Stalevo® 8/20/2010 Stock exchange release 435,019 Orion A-shares converted into B-shares 8/13/2010 Stock exchange release Orion Group Interim Report January-June 2010 8/10/2010 Stock exchange release Orion Corporation's publication schedules for financial reporting in 2011 8/10/2010 Stock exchange release Orion invites analysts and media to Q2 news conference on Tuesday 10 August 2010 7/19/2010 Stock exchange release Orion and Sun settle patent dispute 6/22/2010 Stock exchange release 20,138 Orion A-shares converted into B-shares 6/17/2010 Stock exchange release Composition of R&D Committee as of 15 June 2010 6/15/2010 Stock exchange release Orion upgrades full-year outlook for 2010 6/14/2010 Stock exchange release
